IRIS
INNAO, Vanessa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.334
NA - Nord America 1.275
AS - Asia 252
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.271
IE - Irlanda 422
SE - Svezia 349
IT - Italia 271
PL - Polonia 195
CN - Cina 185
VN - Vietnam 25
IN - India 19
BE - Belgio 17
DE - Germania 17
FI - Finlandia 17
FR - Francia 12
GB - Regno Unito 8
NL - Olanda 7
SG - Singapore 7
UA - Ucraina 6
AT - Austria 5
TW - Taiwan 5
KR - Corea 4
MX - Messico 4
ES - Italia 3
JP - Giappone 3
RU - Federazione Russa 3
EU - Europa 2
ZA - Sudafrica 2
AL - Albania 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
ID - Indonesia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
Totale 2.868
Salva come PNG Salva come JPEG
Città #
Dublin 422
Chandler 384
Nyköping 228
Warsaw 194
Messina 142
Princeton 76
Ashburn 71
Medford 64
Ann Arbor 63
Beijing 59
Des Moines 47
Jacksonville 42
Dearborn 40
Dong Ket 25
Cambridge 18
Wilmington 18
Brussels 17
Jinan 16
Woodbridge 16
New York 14
Boardman 13
Nanjing 13
Rome 13
Pune 12
Tianjin 12
Bremen 11
Hangzhou 10
Hebei 10
Houston 8
Ningbo 8
San Mateo 8
Milan 7
Seattle 7
Shenyang 7
Redwood City 6
Zhengzhou 6
Bengaluru 5
Fuzhou 5
Haikou 5
Lanzhou 5
Los Angeles 5
Strasbourg 5
Vienna 5
Falls Church 4
Helsinki 4
Latina 4
Tappahannock 4
Catania 3
Esher 3
Gangdong-gu 3
Jiaxing 3
Madrid 3
Norwalk 3
Taizhou 3
Turin 3
Cape Town 2
Crosia 2
Guangzhou 2
Hiroshima 2
Modica 2
Monteriggioni 2
Monterrey 2
Nanchang 2
Paris 2
Pescara 2
Piazza Armerina 2
Prospect 2
Qingdao 2
Santo Stefano di Camastra 2
Teramo 2
Tucson 2
Vignola 2
Washington 2
Albignasego 1
Auburn Hills 1
Augusta 1
Brooklyn 1
Cagliari 1
Central 1
Centrale 1
Chatsworth 1
Delft 1
Duncan 1
El Paso 1
Francofonte 1
Fremont 1
Guadalajara 1
Jakarta 1
Kraków 1
Leawood 1
Londrina 1
Manchester 1
Mascalucia 1
Meppel 1
Modena 1
Mountain View 1
Mumbai 1
New Delhi 1
Orta Nova 1
Puxian 1
Totale 2.245
Salva come PNG Salva come JPEG
Nome #
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 99
The cancer stem cell hypothesis: a guide to potential molecular targets. 90
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 84
Role of the microbiota in hematologic malignancies. 83
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 77
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 76
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 74
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management 73
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 73
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 71
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 68
Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patiets’ Characteristics 66
Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study 66
Telomerase and telomere biology in hematological diseases: A new therapeutic target 65
Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network 65
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 63
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 62
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 60
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 58
Vaccination of multiple myeloma: Current strategies and future prospects 57
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 56
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant 53
Vaccination strategies in lymphoproliferative disorders: Failures and successes 52
Lenalidomide maintenance with or without prednisone in newly diagnosed myeloma patients: A pooled analysis 48
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma 48
A multivariate analysis of Multiple Myeloma subtype plasma cells 48
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 47
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 46
IXAZOMIB WITH EITHER DEXAMETHASONE, CYCLOPHOSPHAMIDE-DEXAMETHASONE, THALIDOMIDE-DEXAMETHASONE OR BENDAMUSTINE-DEXAMETHASONE FOLLOWED BY IXAZOMIB MAINTENANCE IN ELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS 46
Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 46
New insights into yes-associated protein signaling pathways in hematological malignancies: Diagnostic and therapeutic challenges 45
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 44
The metabolomic signature of hematologic malignancies 43
Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects 43
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma 42
Mitochondria-targeted antioxidant SkQ1 for gammopathy-related corneal damage 42
Feasibility, Tolerability and Efficacy of Carfilzomib, Lenalidomide and Desamethasone (KRD) in Relapsed Refractory Myeloma Patients: A Real-Life Survey of the Sicilian Myeloma Network 42
Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS. 42
Standardisation of minimal residual disease in multiple myeloma 41
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials 41
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 39
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 39
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 38
A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma 37
The ST2/interleukin-33 axis in hematologic malignancies: The IL-33 paradox 36
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies 35
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review) 34
Nanobodies and Cancer: Current Status and New Perspectives 33
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies 33
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology 33
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. 31
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma 31
Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosphamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age 31
Reviewing the significance of vitamin d substitution in monoclonal gammopathies 27
Therapeutic potential of antagomiRs in haematological and oncological neoplasms 26
Immune thrombocytopenia: options and new perspectives 24
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 22
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease 21
New orally active proteasome inhibitors in multiple myeloma. 19
null 19
Relationship between mitofusin 2 and cancer. 18
Radioprotective agents and enhancers factors. Preventive and therapeutic strategies for oxidative induced radiotherapy damages in hematological malignancies 17
Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma 16
Oncolytic viruses and hematological malignancies: A new class of immunotherapy drugs 16
New frontiers about the role of human microbiota in immunotherapy: The immune checkpoint inhibitors and CAR T-cell therapy era 16
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. 15
Promising anti-mitochondrial agents for overcoming acquired drug resistance in multiple myeloma 14
Immune checkpoint inhibitors in multiple myeloma: A review of the literature 4
Totale 3.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 6 3
2019/2020206 3 1 12 4 8 44 12 2 8 57 42 13
2020/2021651 66 51 101 36 76 29 48 38 61 89 14 42
2021/2022486 4 25 8 22 14 11 27 19 22 96 39 199
2022/20231.278 119 135 65 120 65 123 9 70 505 11 35 21
2023/2024282 22 75 28 26 29 62 2 20 1 17 0 0
Totale 3.069